who knows, these guys spend an awful lot of time

New Post Public Reply Private Reply Replies (0) Message Board
PowerPuncher Pipa #1388

who knows, these guys spend an awful lot of time controlling that iHub board to have zero financial interest. i would suspect they are short the stock. they effectively can cover for less than they should be getting and either they are getting greedy, or they may eventually buy before running up the stock only to exit and short again. a great deal is in mark's hands. disappointed to see his mailbag focused on nothing but two pathetic iHub rants. mark seems like a guy with no plan, he also should be directing the conversation about his stock and company, guiding it towards positive, productive developments for the company and shareholders to get excited about. surely, there is something.

this guy ml is a bit puzzling and hardly seems to help matters. which he could easily begin to do starting, for example, with the share structure. no new serious investors are going to be tempted to take a huge interest in this stock without the share structure. mark has gotten all he can out of those, perhaps, less sophisticated investors, so if he wants to attract more money-- and eventually he will-- he needs to be more transparent. if he can't or won't do that then i think shareholders are stuck and have much bigger things to worry about. the way ml is steering this ship at the moment is not seemingly good. no reason to have a depressing mailbag addressing questions that drag the company down and are meaningless to new investors. that don't entice investment but in fact repel it. mark seems lost, where is the advisory board on this?

someone should have a word with him. putting out that mailbag (as increasingly is the case with ml of late) is worse than saying nothing. why broadcast negativity and stoop down to the iHub crowds rhetoric. they obviously control the board and stock sentiment, ml is doing nothing about it but amplify that fact,

not trying to pick a fight here folks, just sharing an outsiders honest pov. mark needs some help i think, perhaps shareholders can help him realize it. gl2ua

Tytan Holdings Inc. (TYTN) Stock Research Links

TYTN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading